cell-based assay

A cell-based assay tests a compound inside living cells instead of in a tube of purified protein — putting the lock back in the door, inside the house, with all the wiring connected. The compound now has to do everything a real drug must: get into the cell, find its target amid thousands of other molecules, and produce a measurable effect on living machinery.

Cells are treated with the compound and a biologically meaningful change is measured: a reporter gene lighting up, a signaling protein switching state, cells proliferating or dying, calcium flux, or a high-content microscopy image. Because the readout reflects events in an intact cell, a hit here is more likely to translate to real biology — it has already proven it can reach and act on its target in a living context.

The trade-off is interpretability and noise. A cellular readout can change for many reasons — the compound might be toxic, hit an off-target, or fail to enter the cell — so a clean effect does not by itself prove the intended mechanism. Cell-based assays are messier and lower-throughput than biochemical ones, which is why programs often combine the two: biochemical assays for crisp potency, cell-based assays for biological relevance.